Previous authorized capital

(TRANSLATION FROM THE GERMAN LANGUAGE – FOR CONVENIENCE ONLY)

In accordance with the resolution adopted by the Shareholders' Meeting on June 14, 2005 the Executive Board was authorized to create authorized capital of EUR 69,408,066.00 by issuing up to 26,695,410 registered shares of limited transferability.

Click here for further details (available in German only)

In accordance with the resolution adopted by the Shareholders' Meeting in June 2002 the Executive Board had been authorized to create authorized capital of EUR 24,336,000 by issuing up to 9,360,000 registered shares of limited transferability.

Of this total, EUR 17,373,876 had been appropriated in September and October 2003 through the issuance of 6,682,260 registered shares.

Stock exchange listing prospectus/sales prospectus of September 26, 2003 (PDF)
Shareholders' Meeting resolution of June 25, 2002
Authorization of the Executive Board to create authorized capital and to amend the company's articles of association accordingly.

Company profile

Here we have provided you with an overview of important facts and information from strategy through business segments, sales networks and the history of STADA Arzneimittel AG. More

Management

The management of STADA Arzneimittel AG introduce themselves! Here you will find the members of the Executive Board, the Supervisory Board and the Advisory Board. More

Ad hoc & press releases

Here you will find corporate news and ad-hoc releases that you can read directly on your screen or download as a PDF file. Older releases are available for you in our archive. More

Disclosures to WpHG/WpPG

Notices in accordance with the German Securities Trading Act (WpHG) as well as the annual document and the annual financial statements of STADA Arzneimittel AG can be viewed here. More